EverSource Wealth Advisors’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$959 Sell
98
-62
-39% -$612 ﹤0.01% 3978
2026
Q1
$1.55K Buy
160
+70
+78% +$642 ﹤0.01% 3722
2025
Q4
$860 Hold
90
﹤0.01% 3746
2025
Q3
$879 Buy
+90
New +$692 ﹤0.01% 3802
2025
Q2
Sell
-304
Closed -$3.76K 4340
2025
Q1
$3.76K Buy
304
+200
+192% +$2.83K ﹤0.01% 2633
2024
Q4
$1.44K Buy
104
+9
+9% +$142 ﹤0.01% 2845
2024
Q3
$1.59K Hold
95
﹤0.01% 2607
2024
Q2
$2.21K Buy
95
+1
+1% +$22 ﹤0.01% 2519
2024
Q1
$1.91K Buy
94
+1
+1% +$30 ﹤0.01% 2404
2023
Q4
$3.38K Buy
93
+65
+232% +$2.5K ﹤0.01% 2008
2023
Q3
$1.35K Sell
28
-281
-91% -$16.7K ﹤0.01% 2120
2023
Q2
$21.1K Buy
+309
New +$19.9K ﹤0.01% 1134

Other funds holding PRTA

EverSource Wealth Advisors's PRTA Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its Prothena Corp (PRTA) stake by 39% in Q2 2026, selling an estimated $612 and leaving 98 shares worth $959. The position accounts for ﹤0.01% of the portfolio, ranked #3978.

EverSource Wealth Advisors first reported a position in PRTA in Q2 2023 and has held it in 12 quarters since. The position peaked at $21.1K in Q2 2023. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • EverSource Wealth Advisors held 98 shares of Prothena Corp worth $959 as of Q2 2026.
  • EverSource Wealth Advisors sold 62 Prothena Corp shares in Q2 2026, an estimated $612.
  • Prothena Corp made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3978 holding.
  • EverSource Wealth Advisors first reported a position in Prothena Corp in Q2 2023 and has held it in 12 quarters since.
  • EverSource Wealth Advisors's Prothena Corp position peaked at $21.1K in Q2 2023.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.